Monday, January 9, 2017

One of the players died crime in Iran

 Influential former Iranian regime president, Hashemi Rafsanjani died at age 82

Influential former Iranian regime president, Hashemi Rafsanjani died at age 82

prison on charges of criticizing the ruling system.
In 2013, Iran's election watchdog rejected his nomination for the presidential campaign, hinting at his age.
In 2015, a court sentenced his younger son, Mahdi, to a 10-year prison term over embezzlement and security charges.
Rafsanjani is survived by his wife, Effat Marashi, and five children.

TEHRAN, Iran, Jan. 8, 2017 — Former Iranian President Akbar Hashemi Rafsanjani, a wily political survivor and multimillionaire mogul who remained among the ruling elite, died Sunday, state TV reported. He was 82.
Iranian media reported earlier Sunday that he was taken to a hospital north of Tehran because of a heart condition. State television broke into programming to announce his death.
Rafsanjani's mix of sly wit and reputation for cunning moves — both in politics and business — earned him a host of nicknames such as Akbar Shah during a life that touched every major event in Iranian affairs since before the 1979 Islamic Revolution.


While Rafsanjani was blocked from the 2013 ballot by Iran's election overseers — presumably worried about boosting his already wide-ranging influence — the former leader embraced Rouhani's success.
'Now I can easily die since people are able to decide their fate by themselves,' he reportedly said last March.
However, Rouhani now faces a crucial presidential election in May which will serve as a referendum on the deal and thawing relations with the West.
Rafsanjani was sharply critical of a move by Iran's constitutional watchdog to block Hassan Khomeini, the grandson of the Islamic Republic's founder, from running for a top clerical body in elections last year.
Rafsanjani was a close aide of Khomeini and served as president from 1989 to 1997 during a period of significant changes in Iran.

Read more on the Ling

No comments:

Post a Comment